Citeline Podcasts

In this edition of Device Week, Medtech Insight’s Tina Tan chats to Catherine Longworth about the recent surge in M&A deal-making and wonder if this would impact 2017’s overall outlook. They also chat about Merck’s ambitions to be an all-round leader in fertility treatment, for both drugs and devices and what makes Ireland continue to be an attractive medtech hub for generating innovation.

For more information on Medtech Insight and to start a free trial, click here: http://bit.ly/2w7LnlR

Medtech Insight articles addressing topics discussed in this episode:

Stryker's Deal For Spine Device Maker Vexim Rounds Up Ortho M&A Trilogy http://bit.ly/2hpvIXc

Smith & Nephew To Acquire Regenerative Shoulder-Tech Firm http://bit.ly/2gNNBxY

Merck On A Mission To Introduce Automation To Fertility Treatment http://bit.ly/2zjbg4v

Innovation Driving Ireland's Transition From Medtech Supplier To Strategic Partner http://bit.ly/2xyBU4U

This is Compliance 360°, a podcast series from Medtech Insight on US FDA compliance and enforcement issues. In this 11th installment – the second of two parts – former FDA investigations branch director Ricki Chase discusses some of the more complex problems that may arise in the relationship between the owners of regulated products and contract manufacturing organizations (CMOs), and how to solve them.

On this week’s podcast, we talk about how artificial intelligence is being used in the quality and regulatory arenas to review, sort and process big data to find quality systems or product problems.

In a broad chat with top officials at AdvaMed, and the Health Care and Public Health Safety Sector Council, Medtech Insight dives into what the groups have been up to to encourage better cybersecurity on medical devices and how they see the world evolving.

This is Compliance 360°, a podcast series from Medtech Insight on US FDA compliance and enforcement issues. In this 10th installment – the first of two parts – former FDA investigations branch director Ricki Chase explains how owners of regulated products can learn "tricks" to managing their relationships with contract manufacturing organizations (CMOs) to avoid being "treated" to an FDA-483 inspection observation form.

On this week's podcast, we highlight progress by several startups in the molecular diagnostics space, and discuss growing scrutiny in the cardiology community of Boston Scientific's Watchman stroke device. For more information on Medtech Insight and to start a free trial, click here: bit.ly/2w7LnlR

Medtech Insight articles addressed in this episode:

• genedrive Signs Sysmex To Distribute Decentralized-Setting HCV Test: http://bit.ly/2zmkpW3

• MDxHealth Gears Up For Major EU Growth: http://bit.ly/2zlCeo9

Partnering In The Pharma World Podcast

• life science partnering conference

• Bio Europe 2017

• 23RD Annual International Partnering Conference

• Partnering in the Pharma World

In this edition of Device Week, Medtech Insight’s Tina Tan chats to Marion Webb about AdvaMed’s annual Medtech Conference held at the end of September and which were the most interesting startups showcased at the meeting. She also speaks to Reed Miller to discuss the more notable M&A deals that have happened in this recent surge of acquisition activity.

For more information on Medtech Insight and to start a free trial, click here: http://bit.ly/2w7LnlR

Medtech Insight articles addressing topics discussed in this episode:

Medtronic Stands To Be Biggest Beneficiary Of J&J's Exit From Insulin Pump Market http://bit.ly/2zfE2zX

From AI-Based IVDs To Precision Drug Dosing: Medtech Conference 2017 Gives Insight Into Tomorrow's Technologies http://bit.ly/2kFpkz4

Rose Sheet’s editorial team counts down top news items in the cosmetics and dietary supplement sectors over the past month, including possible cosmetics regulatory convergence under a renegotiated NAFTA, the FTC’s first enforcement action against social media influencers, FDA movement to develop a list of “old dietary ingredients” pre-dating DSHEA, and more.

On this week’s podcast, we discuss big announcements from FDA at AdvaMed’s recent MedTech Conference on digital health policy and an upcoming device-center reorganization, as well as the recent resignation of Tom Price as US HHS secretary. For more information on Medtech Insight and to start a free trial, click here: http://bit.ly/2w7LnlR

Medtech Insight articles addressing topics discussed in this episode:

'Excellence' In Health-Software Design: US FDA Taps Nine Firms To Figure Out What That Means: http://bit.ly/2fUcyuV

Gottlieb At The Medtech Conference: US FDA Commissioner Talks About CDRH Innovation, Puerto Rico, LDTs And More: http://bit.ly/2hP0Fae

'Super Office' To The Rescue: FDA's Device Center Is About To Undergo A 'Total Product Life Cycle' Makeover: http://bit.ly/2yKvgIY

HHS Secretary Tom Price Resigns Over Free-Flights Flap: http://bit.ly/2fPuP98